TREM2 Variants in Alzheimer's Disease
Author(s) -
Rita Guerreiro,
Aleksandra Wojtas,
José Brás,
Minerva M. Carrasquillo,
Ekaterina Rogaeva,
Elisa Majounie,
Carlos Cruchaga,
Celeste Sassi,
John Kauwe,
Steven G. Younkin,
LiliNaz Hazrati,
John Collinge,
Jennifer M. Pocock,
Tammaryn Lashley,
Julie Williams,
JeanCharles Lambert,
Philippe Amouyel,
Alison Goate,
Rosa Rademakers,
Kevin Morgan,
John Powell,
Peter St GeorgeHyslop,
Andrew Singleton,
John Hardy
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1211851
Subject(s) - trem2 , dementia , loss function , disease , genetics , biology , gain of function , mutation , myeloid , receptor , function (biology) , alzheimer's disease , medicine , myeloid cells , cancer research , gene , phenotype
Homozygous loss-of-function mutations in TREM2, encoding the triggering receptor expressed on myeloid cells 2 protein, have previously been associated with an autosomal recessive form of early-onset dementia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom